AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionSchroder Investment Management Group
Latest Disclosed Ownership2,216,285 shares
Latest Disclosed Value $ 472,334,660
Schroder Investment Management Group reports 30.81% decrease in ownership of ABBV / AbbVie Inc.

On May 14, 2026 - Schroder Investment Management Group filed a 13F-HR form disclosing ownership of 2,216,285 shares of AbbVie Inc. (MX:ABBV) valued at $472,334,660 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 3,203,366 shares of AbbVie Inc.. This represents a change in shares of -30.81% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 2,216,285 -987,081 -30.81 472,335 -35.47 0.3873
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 3,203,366 395,029 14.07 731,937 12.56 0.5549
2025-11-13 2025-09-30 13F ABBVIE COM 00287Y109 2,808,337 243,666 9.50 650,242 36.59 0.5087
2025-08-13 2025-06-30 13F ABBVIE COM 00287Y109 2,564,671 -176,770 -6.45 476,054 -17.12 0.4024
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 2,741,441 315,336 13.00 574,387 33.23 0.5799
2025-02-12 2024-12-31 13F ABBVIE COM 00287Y109 2,426,105 -235,739 -8.86 431,119 -17.99 0.4131
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 2,661,844 568,539 27.16 525,661 46.41 0.5387
2024-08-12 2024-06-30 13F ABBVIE COM 00287Y109 2,093,305 227,534 12.20 359,044 5.68 0.3960
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 1,865,771 -27,760 -1.47 339,757 15.78 0.3996
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 1,893,531 60,942 3.33 293,440 7.42 0.3804
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 1,832,589 362,449 24.65 273,166 37.91 0.4064
2023-08-11 2023-06-30 13F ABBVIE COM 00287Y109 1,470,140 41,628 2.91 198,072 -13.00 0.2841
2023-05-11 2023-03-31 13F ABBVIE COM 00287Y109 1,428,512 -111,087 -7.22 227,662 -8.50 0.3386
2023-02-10 2022-12-31 13F ABBVIE COM 00287Y109 1,539,599 -358,076 -18.87 248,815 -2.31 0.3950
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 1,897,675 -116,660 -5.79 254,687 -17.97 0.4214
2022-08-11 2022-06-30 13F ABBVIE COM 00287Y109 2,014,335 227,618 12.74 310,490 6.12 0.4730
2022-05-16 2022-03-31 13F ABBVIE COM 00287Y109 1,786,717 -503,947 -22.00 292,574 -5.67 0.3865
2022-02-14 2021-12-31 13F AbbVie COM 00287Y109 2,290,664 289,498 14.47 310,156 43.68 0.4050
2021-11-12 2021-09-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,001,166 210,677 11.77 215,866 7.03 0.3320
2021-08-13 2021-06-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 1,790,489 -35,634 -1.95 201,681 2.05 0.2526
2021-05-28 2021-03-31 13F/A-1 ABBVIE INCORPORATED USD0.01 COM 00287Y109 1,826,123 103,972 6.04 197,623 107,303.80 0.2564
2021-05-17 2021-03-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 1,826,123 103,972 197,623 0.2564
2021-02-24 2020-12-31 13F/A-1 ABBVIE INCORPORATED USD0.01 COM 00287Y109 1,722,151 -217,705 -11.22 185 -99.89 0.2606
2021-02-16 2020-12-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 1,722,151 -217,705 185 0.2576
2020-11-13 2020-09-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 1,939,856 -69,980 -3.48 167,060 -15.34 0.2671
2020-08-13 2020-06-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,009,836 -284,160 -12.39 197,326 13.59 0.3579
2020-05-15 2020-03-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,293,996 -477,402 -17.23 173,724 -29.20 0.3716
2020-02-11 2019-12-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,771,398 -1,302,639 -31.97 245,379 -19.53 0.3997
2019-11-12 2019-09-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 4,074,037 738,176 22.13 304,941 25.71 0.5377
2019-11-14 2019-06-30 13F/A-2 ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,335,861 8,049 0.24 242,584 -9.55 0.4411
2019-08-15 2019-06-30 13F/A-1 ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,335,861 0 242,584 0.2602
2019-08-08 2019-06-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,335,861 8,049 242,584 260,256.6218
2019-11-15 2019-03-31 13F/A-1 ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,327,812 646,051 24.09 268,189 8.48 0.4775
2019-05-14 2019-03-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,327,812 646,051 268,189 435,594.1467
2019-02-14 2018-12-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,681,761 324,587 13.77 247,232 10.90 0.4473
2018-11-13 2018-09-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,357,174 -122,786 -4.95 222,941 -2.74 0.3829
2018-08-23 2018-06-30 13F/A-2 ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,479,960 451,903 22.28 229,223 19.41 0.4013
2018-08-16 2018-06-30 13F/A-1 ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,479,960 0 229,223 0.4013
2018-08-13 2018-06-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,479,960 451,903 229,223 405,889.7476
2018-05-11 2018-03-31 13F/A-1 ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,028,057 -15,839 -0.77 191,955 -2.89 0.3326
2018-05-11 2018-03-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,028,057 -15,839 191,955 332,642.3495
2018-02-09 2017-12-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,043,896 -156,890 -7.13 197,666 0.96 0.3235
2017-11-09 2017-09-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,200,786 -1,254,672 -36.31 195,783 -21.83 0.3402
2017-08-10 2017-06-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,455,458 -214,262 -5.84 250,453 4.26 0.4515
2017-05-18 2017-03-31 13F/A-1 ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,669,720 386,943 11.79 240,220 16.86 0.4317
2017-05-10 2017-03-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,669,720 386,943 240,220 431,793.9782
2017-02-10 2016-12-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,282,777 328,433 11.12 205,568 10.33 0.3935
2016-11-09 2016-09-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 2,954,344 2,021,049 216.55 186,329 222.49 0.3480
2016-08-08 2016-06-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 933,295 364,843 64.18 57,779 78.32 0.1160
2016-05-10 2016-03-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 568,452 333,858 142.31 32,402 133.14 0.0670
2016-02-10 2015-12-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 234,594 -282,743 -54.65 13,898 -50.63 0.0287
2015-11-13 2015-09-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 517,337 -203,688 -28.25 28,148 -41.89 0.0595
2015-08-10 2015-06-30 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 721,025 -3,972,594 -84.64 48,439 -82.10 0.0952
2015-05-12 2015-03-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 4,693,619 1,321,645 39.19 270,588 22.63 0.5290
2015-02-18 2014-12-31 13F/A-1 ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,371,974 -653,633 220,662 0.4327
2015-02-25 2014-12-31 13F/A-2 ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,371,974 -653,633 -16.24 220,662 -5.10 0.4331
2015-02-17 2014-12-31 13F ABBVIE INCORPORATED USD0.01 COM 00287Y109 3,371,974 -653,633 220,662 320,409.6513
2014-11-13 2014-09-30 13F AbbVie Inc Common Stk USD0.01 COM 00287Y109 4,025,607 -761,812 -15.91 232,519 -13.95 0.3104
2014-08-13 2014-06-30 13F AbbVie Inc Common Stk USD0 01 COM 00287Y109 4,787,419 -329,190 -6.43 270,202 2.74 0.3356
2014-05-15 2014-03-31 13F AbbVie Inc Common Stk USD0.01 COM 00287Y109 5,116,609 851,329 19.96 262,994 16.76 0.2964
2014-02-14 2013-12-31 13F AbbVie Inc Common Stk USD0.01 COM 00287Y109 4,265,280 -1,095,014 -20.43 225,249 -6.05 0.2815
2013-12-09 2013-09-30 13F/A-1 AbbVie Inc Common Stk USD0.01 COM 00287Y109 239,765,950 235,063,526 10,724,731 0.3231
2013-12-10 2013-09-30 13F/A-2 AbbVie Inc Common Stk USD0.01 COM 00287Y109 5,360,294 657,870 13.99 239,766 23.34 0.5821
2013-11-08 2013-09-30 13F AbbVie Inc Common Stk USD0.01 COM 00287Y109 5,336,017 633,593 238,680 588.9760
2013-08-12 2013-06-30 13F AbbVie Inc Common Stk USD0.01 COM 00287Y109 4,702,424 4,702,424 194,398 0.5143
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.